nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—PTGS1—kidney cancer	0.122	0.486	CbGaD
Indomethacin—PTGS2—kidney cancer	0.0697	0.278	CbGaD
Indomethacin—ABCB1—kidney cancer	0.0593	0.236	CbGaD
Indomethacin—ABCC6—Dactinomycin—kidney cancer	0.0566	0.118	CbGbCtD
Indomethacin—CES1—Capecitabine—kidney cancer	0.0467	0.0976	CbGbCtD
Indomethacin—ABCC6—Vinblastine—kidney cancer	0.0355	0.0741	CbGbCtD
Indomethacin—AKR1C3—Doxorubicin—kidney cancer	0.029	0.0606	CbGbCtD
Indomethacin—UGT1A1—Pazopanib—kidney cancer	0.0222	0.0464	CbGbCtD
Indomethacin—ABCC6—Doxorubicin—kidney cancer	0.0218	0.0455	CbGbCtD
Indomethacin—ABCC3—Vincristine—kidney cancer	0.0167	0.035	CbGbCtD
Indomethacin—ABCC1—Dactinomycin—kidney cancer	0.0167	0.0349	CbGbCtD
Indomethacin—UGT1A1—Erlotinib—kidney cancer	0.0158	0.0331	CbGbCtD
Indomethacin—UGT1A9—Sorafenib—kidney cancer	0.0158	0.0329	CbGbCtD
Indomethacin—SLCO1B1—Pazopanib—kidney cancer	0.0154	0.0321	CbGbCtD
Indomethacin—ABCC4—Sorafenib—kidney cancer	0.0132	0.0276	CbGbCtD
Indomethacin—UGT1A1—Sorafenib—kidney cancer	0.0129	0.0269	CbGbCtD
Indomethacin—ABCC1—Paclitaxel—kidney cancer	0.0119	0.0249	CbGbCtD
Indomethacin—ABCC4—Sunitinib—kidney cancer	0.0107	0.0223	CbGbCtD
Indomethacin—ABCC3—Doxorubicin—kidney cancer	0.0105	0.0219	CbGbCtD
Indomethacin—ABCC1—Vinblastine—kidney cancer	0.0105	0.0219	CbGbCtD
Indomethacin—ABCC1—Vincristine—kidney cancer	0.0103	0.0215	CbGbCtD
Indomethacin—ABCC2—Paclitaxel—kidney cancer	0.00883	0.0185	CbGbCtD
Indomethacin—ABCB1—Temsirolimus—kidney cancer	0.00838	0.0175	CbGbCtD
Indomethacin—ABCC2—Sorafenib—kidney cancer	0.00784	0.0164	CbGbCtD
Indomethacin—ABCC2—Vinblastine—kidney cancer	0.00774	0.0162	CbGbCtD
Indomethacin—ABCC2—Vincristine—kidney cancer	0.00761	0.0159	CbGbCtD
Indomethacin—ABCC1—Doxorubicin—kidney cancer	0.00643	0.0134	CbGbCtD
Indomethacin—ABCC2—Sunitinib—kidney cancer	0.00635	0.0133	CbGbCtD
Indomethacin—ALB—Erlotinib—kidney cancer	0.00601	0.0126	CbGbCtD
Indomethacin—ABCC2—Doxorubicin—kidney cancer	0.00476	0.00994	CbGbCtD
Indomethacin—CYP2C9—Capecitabine—kidney cancer	0.00473	0.0099	CbGbCtD
Indomethacin—ABCB1—Pazopanib—kidney cancer	0.0044	0.00921	CbGbCtD
Indomethacin—ABCB1—Dactinomycin—kidney cancer	0.00403	0.00842	CbGbCtD
Indomethacin—ABCB1—Gemcitabine—kidney cancer	0.00318	0.00666	CbGbCtD
Indomethacin—CYP2C19—Sorafenib—kidney cancer	0.00317	0.00662	CbGbCtD
Indomethacin—ABCB1—Erlotinib—kidney cancer	0.00314	0.00657	CbGbCtD
Indomethacin—CYP2C9—Paclitaxel—kidney cancer	0.00296	0.0062	CbGbCtD
Indomethacin—ABCB1—Paclitaxel—kidney cancer	0.00288	0.00602	CbGbCtD
Indomethacin—CYP2C9—Sorafenib—kidney cancer	0.00263	0.00551	CbGbCtD
Indomethacin—ABCB1—Sorafenib—kidney cancer	0.00256	0.00534	CbGbCtD
Indomethacin—ABCB1—Vinblastine—kidney cancer	0.00252	0.00528	CbGbCtD
Indomethacin—ABCB1—Vincristine—kidney cancer	0.00248	0.00519	CbGbCtD
Indomethacin—UGT1A1—urine—kidney cancer	0.00241	0.0444	CbGeAlD
Indomethacin—PPARG—nephron—kidney cancer	0.00216	0.0397	CbGeAlD
Indomethacin—ABCB1—Sunitinib—kidney cancer	0.00207	0.00433	CbGbCtD
Indomethacin—SLC22A8—nephron—kidney cancer	0.00194	0.0358	CbGeAlD
Indomethacin—SLC22A8—urine—kidney cancer	0.00156	0.0287	CbGeAlD
Indomethacin—ABCB1—Doxorubicin—kidney cancer	0.00155	0.00324	CbGbCtD
Indomethacin—PTGR2—renal system—kidney cancer	0.00144	0.0264	CbGeAlD
Indomethacin—PTGR2—kidney—kidney cancer	0.00139	0.0256	CbGeAlD
Indomethacin—PTGR2—cortex of kidney—kidney cancer	0.00135	0.0249	CbGeAlD
Indomethacin—CYP2C19—urine—kidney cancer	0.00131	0.0241	CbGeAlD
Indomethacin—PTGR2—cardiac atrium—kidney cancer	0.00129	0.0237	CbGeAlD
Indomethacin—ABCC11—gonad—kidney cancer	0.00127	0.0235	CbGeAlD
Indomethacin—PTGS2—nephron—kidney cancer	0.0011	0.0203	CbGeAlD
Indomethacin—CYP2C9—urine—kidney cancer	0.00101	0.0187	CbGeAlD
Indomethacin—GLO1—nephron tubule—kidney cancer	0.000976	0.018	CbGeAlD
Indomethacin—CXCL8—nephron tubule—kidney cancer	0.000898	0.0165	CbGeAlD
Indomethacin—GLO1—renal system—kidney cancer	0.000887	0.0163	CbGeAlD
Indomethacin—UGT1A9—renal system—kidney cancer	0.000861	0.0159	CbGeAlD
Indomethacin—GLO1—kidney—kidney cancer	0.000857	0.0158	CbGeAlD
Indomethacin—GLO1—cortex of kidney—kidney cancer	0.000835	0.0154	CbGeAlD
Indomethacin—UGT1A9—kidney—kidney cancer	0.000832	0.0153	CbGeAlD
Indomethacin—PLA2G2A—renal system—kidney cancer	0.000825	0.0152	CbGeAlD
Indomethacin—ABCC6—renal system—kidney cancer	0.000816	0.015	CbGeAlD
Indomethacin—PLA2G2A—kidney—kidney cancer	0.000797	0.0147	CbGeAlD
Indomethacin—GLO1—gonad—kidney cancer	0.000795	0.0146	CbGeAlD
Indomethacin—GLO1—cardiac atrium—kidney cancer	0.000794	0.0146	CbGeAlD
Indomethacin—ABCC6—kidney—kidney cancer	0.000789	0.0145	CbGeAlD
Indomethacin—PPARA—renal system—kidney cancer	0.00077	0.0142	CbGeAlD
Indomethacin—AKR1C3—Vincristine—Vinblastine—kidney cancer	0.000762	0.375	CbGdCrCtD
Indomethacin—PPARA—kidney—kidney cancer	0.000745	0.0137	CbGeAlD
Indomethacin—SLC22A11—nephron tubule—kidney cancer	0.000744	0.0137	CbGeAlD
Indomethacin—SLC10A1—renal system—kidney cancer	0.000741	0.0136	CbGeAlD
Indomethacin—PLA2G2A—cardiac atrium—kidney cancer	0.000738	0.0136	CbGeAlD
Indomethacin—SLC10A1—kidney—kidney cancer	0.000716	0.0132	CbGeAlD
Indomethacin—AKR1C3—nephron tubule—kidney cancer	0.000704	0.013	CbGeAlD
Indomethacin—SLC22A6—nephron tubule—kidney cancer	0.000701	0.0129	CbGeAlD
Indomethacin—UGT2B7—renal system—kidney cancer	0.000694	0.0128	CbGeAlD
Indomethacin—SLC22A11—renal system—kidney cancer	0.000676	0.0125	CbGeAlD
Indomethacin—UGT2B7—kidney—kidney cancer	0.000671	0.0124	CbGeAlD
Indomethacin—SLC10A1—gonad—kidney cancer	0.000664	0.0122	CbGeAlD
Indomethacin—SLC22A7—renal system—kidney cancer	0.00066	0.0122	CbGeAlD
Indomethacin—PPARG—Everolimus—Temsirolimus—kidney cancer	0.000657	0.323	CbGdCrCtD
Indomethacin—SLC22A11—kidney—kidney cancer	0.000654	0.012	CbGeAlD
Indomethacin—SLC22A7—kidney—kidney cancer	0.000638	0.0118	CbGeAlD
Indomethacin—SLC22A11—cortex of kidney—kidney cancer	0.000637	0.0117	CbGeAlD
Indomethacin—SLC22A7—cortex of kidney—kidney cancer	0.000622	0.0114	CbGeAlD
Indomethacin—AKR1C3—Vinblastine—Vincristine—kidney cancer	0.000613	0.302	CbGdCrCtD
Indomethacin—AKR1C3—cortex of kidney—kidney cancer	0.000603	0.0111	CbGeAlD
Indomethacin—SLC22A6—cortex of kidney—kidney cancer	0.0006	0.0111	CbGeAlD
Indomethacin—UGT1A1—renal system—kidney cancer	0.00059	0.0109	CbGeAlD
Indomethacin—Bromfenac—PTGS1—kidney cancer	0.000574	0.255	CrCbGaD
Indomethacin—AKR1C3—cardiac atrium—kidney cancer	0.000573	0.0106	CbGeAlD
Indomethacin—UGT1A1—kidney—kidney cancer	0.000571	0.0105	CbGeAlD
Indomethacin—SLCO1B1—renal system—kidney cancer	0.000491	0.00904	CbGeAlD
Indomethacin—SLCO1B1—kidney—kidney cancer	0.000475	0.00874	CbGeAlD
Indomethacin—ABCC3—renal system—kidney cancer	0.000466	0.00858	CbGeAlD
Indomethacin—ABCC3—kidney—kidney cancer	0.00045	0.00829	CbGeAlD
Indomethacin—PPARG—renal system—kidney cancer	0.000424	0.0078	CbGeAlD
Indomethacin—ABCC4—nephron tubule—kidney cancer	0.000423	0.00779	CbGeAlD
Indomethacin—SLC22A8—nephron tubule—kidney cancer	0.00042	0.00773	CbGeAlD
Indomethacin—ABCC2—nephron tubule—kidney cancer	0.00041	0.00754	CbGeAlD
Indomethacin—PPARG—kidney—kidney cancer	0.000409	0.00754	CbGeAlD
Indomethacin—SLCO1A2—renal system—kidney cancer	0.0004	0.00736	CbGeAlD
Indomethacin—SLCO1A2—kidney—kidney cancer	0.000386	0.00711	CbGeAlD
Indomethacin—Tolmetin—PTGS1—kidney cancer	0.000386	0.171	CrCbGaD
Indomethacin—ABCC4—renal system—kidney cancer	0.000385	0.00708	CbGeAlD
Indomethacin—SLC22A8—renal system—kidney cancer	0.000382	0.00703	CbGeAlD
Indomethacin—ABCC2—renal system—kidney cancer	0.000372	0.00686	CbGeAlD
Indomethacin—ABCC4—kidney—kidney cancer	0.000372	0.00685	CbGeAlD
Indomethacin—SLC22A8—kidney—kidney cancer	0.000369	0.00679	CbGeAlD
Indomethacin—ABCC4—cortex of kidney—kidney cancer	0.000362	0.00667	CbGeAlD
Indomethacin—ABCC2—kidney—kidney cancer	0.00036	0.00663	CbGeAlD
Indomethacin—SLC22A8—cortex of kidney—kidney cancer	0.000359	0.00662	CbGeAlD
Indomethacin—ABCC2—cortex of kidney—kidney cancer	0.000351	0.00645	CbGeAlD
Indomethacin—Bromfenac—PTGS2—kidney cancer	0.000328	0.146	CrCbGaD
Indomethacin—ABCC1—cortex of kidney—kidney cancer	0.000309	0.00569	CbGeAlD
Indomethacin—ABCC1—cardiac atrium—kidney cancer	0.000294	0.00541	CbGeAlD
Indomethacin—Naproxen—PTGS1—kidney cancer	0.00029	0.129	CrCbGaD
Indomethacin—Bezafibrate—CYP1A1—kidney cancer	0.00029	0.129	CrCbGaD
Indomethacin—PTGS1—renal system—kidney cancer	0.000226	0.00417	CbGeAlD
Indomethacin—Tolmetin—PTGS2—kidney cancer	0.000221	0.0978	CrCbGaD
Indomethacin—PTGS1—kidney—kidney cancer	0.000219	0.00403	CbGeAlD
Indomethacin—PTGS2—renal system—kidney cancer	0.000216	0.00399	CbGeAlD
Indomethacin—PTGS2—kidney—kidney cancer	0.000209	0.00385	CbGeAlD
Indomethacin—PTGS1—cardiac atrium—kidney cancer	0.000203	0.00373	CbGeAlD
Indomethacin—Naproxen—PTGS2—kidney cancer	0.000166	0.0736	CrCbGaD
Indomethacin—ABCB1—nephron tubule—kidney cancer	0.000147	0.00271	CbGeAlD
Indomethacin—ABCB1—renal system—kidney cancer	0.000134	0.00247	CbGeAlD
Indomethacin—ABCB1—kidney—kidney cancer	0.000129	0.00238	CbGeAlD
Indomethacin—ABCB1—cortex of kidney—kidney cancer	0.000126	0.00232	CbGeAlD
Indomethacin—ABCB1—gonad—kidney cancer	0.00012	0.00221	CbGeAlD
Indomethacin—Headache—Everolimus—kidney cancer	6.19e-05	0.000457	CcSEcCtD
Indomethacin—Hypotension—Gemcitabine—kidney cancer	6.19e-05	0.000457	CcSEcCtD
Indomethacin—Abdominal pain—Dactinomycin—kidney cancer	6.18e-05	0.000456	CcSEcCtD
Indomethacin—Body temperature increased—Dactinomycin—kidney cancer	6.18e-05	0.000456	CcSEcCtD
Indomethacin—Asthenia—Sorafenib—kidney cancer	6.16e-05	0.000454	CcSEcCtD
Indomethacin—Malaise—Paclitaxel—kidney cancer	6.13e-05	0.000452	CcSEcCtD
Indomethacin—Hypoglycaemia—Doxorubicin—kidney cancer	6.12e-05	0.000451	CcSEcCtD
Indomethacin—Vertigo—Paclitaxel—kidney cancer	6.11e-05	0.00045	CcSEcCtD
Indomethacin—Syncope—Paclitaxel—kidney cancer	6.1e-05	0.00045	CcSEcCtD
Indomethacin—Leukopenia—Paclitaxel—kidney cancer	6.09e-05	0.000449	CcSEcCtD
Indomethacin—Hypersensitivity—Sunitinib—kidney cancer	6.09e-05	0.000449	CcSEcCtD
Indomethacin—Decreased appetite—Vincristine—kidney cancer	6.07e-05	0.000448	CcSEcCtD
Indomethacin—Pruritus—Sorafenib—kidney cancer	6.07e-05	0.000448	CcSEcCtD
Indomethacin—Vomiting—Erlotinib—kidney cancer	6.07e-05	0.000447	CcSEcCtD
Indomethacin—Erythema multiforme—Capecitabine—kidney cancer	6.06e-05	0.000447	CcSEcCtD
Indomethacin—Fatigue—Vincristine—kidney cancer	6.02e-05	0.000444	CcSEcCtD
Indomethacin—Rash—Erlotinib—kidney cancer	6.02e-05	0.000444	CcSEcCtD
Indomethacin—Dermatitis—Erlotinib—kidney cancer	6.01e-05	0.000443	CcSEcCtD
Indomethacin—Palpitations—Paclitaxel—kidney cancer	6.01e-05	0.000443	CcSEcCtD
Indomethacin—Hyponatraemia—Doxorubicin—kidney cancer	6e-05	0.000442	CcSEcCtD
Indomethacin—Insomnia—Gemcitabine—kidney cancer	5.99e-05	0.000442	CcSEcCtD
Indomethacin—Headache—Erlotinib—kidney cancer	5.98e-05	0.000441	CcSEcCtD
Indomethacin—Tinnitus—Capecitabine—kidney cancer	5.98e-05	0.000441	CcSEcCtD
Indomethacin—Loss of consciousness—Paclitaxel—kidney cancer	5.98e-05	0.000441	CcSEcCtD
Indomethacin—Pain—Vincristine—kidney cancer	5.97e-05	0.000441	CcSEcCtD
Indomethacin—Constipation—Vincristine—kidney cancer	5.97e-05	0.000441	CcSEcCtD
Indomethacin—Osteoarthritis—Doxorubicin—kidney cancer	5.97e-05	0.00044	CcSEcCtD
Indomethacin—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	5.97e-05	0.00044	CcSEcCtD
Indomethacin—Diplopia—Doxorubicin—kidney cancer	5.97e-05	0.00044	CcSEcCtD
Indomethacin—Paraesthesia—Gemcitabine—kidney cancer	5.95e-05	0.000439	CcSEcCtD
Indomethacin—Flushing—Capecitabine—kidney cancer	5.95e-05	0.000439	CcSEcCtD
Indomethacin—Asthenia—Sunitinib—kidney cancer	5.93e-05	0.000437	CcSEcCtD
Indomethacin—Dyspnoea—Gemcitabine—kidney cancer	5.91e-05	0.000436	CcSEcCtD
Indomethacin—Nausea—Vinblastine—kidney cancer	5.9e-05	0.000435	CcSEcCtD
Indomethacin—Somnolence—Gemcitabine—kidney cancer	5.89e-05	0.000434	CcSEcCtD
Indomethacin—Convulsion—Paclitaxel—kidney cancer	5.89e-05	0.000434	CcSEcCtD
Indomethacin—Nausea—Everolimus—kidney cancer	5.87e-05	0.000433	CcSEcCtD
Indomethacin—Diarrhoea—Sorafenib—kidney cancer	5.87e-05	0.000433	CcSEcCtD
Indomethacin—Hypertension—Paclitaxel—kidney cancer	5.87e-05	0.000433	CcSEcCtD
Indomethacin—Pruritus—Sunitinib—kidney cancer	5.84e-05	0.000431	CcSEcCtD
Indomethacin—Chest pain—Paclitaxel—kidney cancer	5.79e-05	0.000427	CcSEcCtD
Indomethacin—Anxiety—Paclitaxel—kidney cancer	5.77e-05	0.000425	CcSEcCtD
Indomethacin—Decreased appetite—Gemcitabine—kidney cancer	5.76e-05	0.000425	CcSEcCtD
Indomethacin—Hypersensitivity—Dactinomycin—kidney cancer	5.76e-05	0.000425	CcSEcCtD
Indomethacin—Arrhythmia—Capecitabine—kidney cancer	5.73e-05	0.000422	CcSEcCtD
Indomethacin—Discomfort—Paclitaxel—kidney cancer	5.72e-05	0.000422	CcSEcCtD
Indomethacin—Fatigue—Gemcitabine—kidney cancer	5.71e-05	0.000421	CcSEcCtD
Indomethacin—Gastrointestinal pain—Vincristine—kidney cancer	5.71e-05	0.000421	CcSEcCtD
Indomethacin—Dizziness—Sorafenib—kidney cancer	5.68e-05	0.000419	CcSEcCtD
Indomethacin—Pain—Gemcitabine—kidney cancer	5.67e-05	0.000418	CcSEcCtD
Indomethacin—Constipation—Gemcitabine—kidney cancer	5.67e-05	0.000418	CcSEcCtD
Indomethacin—Nausea—Erlotinib—kidney cancer	5.67e-05	0.000418	CcSEcCtD
Indomethacin—Alopecia—Capecitabine—kidney cancer	5.66e-05	0.000418	CcSEcCtD
Indomethacin—Diarrhoea—Sunitinib—kidney cancer	5.65e-05	0.000417	CcSEcCtD
Indomethacin—Asthenia—Dactinomycin—kidney cancer	5.61e-05	0.000414	CcSEcCtD
Indomethacin—Confusional state—Paclitaxel—kidney cancer	5.59e-05	0.000413	CcSEcCtD
Indomethacin—Erythema—Capecitabine—kidney cancer	5.58e-05	0.000411	CcSEcCtD
Indomethacin—Anaphylactic shock—Paclitaxel—kidney cancer	5.55e-05	0.000409	CcSEcCtD
Indomethacin—Oedema—Paclitaxel—kidney cancer	5.55e-05	0.000409	CcSEcCtD
Indomethacin—Abdominal pain—Vincristine—kidney cancer	5.52e-05	0.000407	CcSEcCtD
Indomethacin—Body temperature increased—Vincristine—kidney cancer	5.52e-05	0.000407	CcSEcCtD
Indomethacin—Flatulence—Capecitabine—kidney cancer	5.5e-05	0.000405	CcSEcCtD
Indomethacin—Dizziness—Sunitinib—kidney cancer	5.46e-05	0.000403	CcSEcCtD
Indomethacin—Feeling abnormal—Gemcitabine—kidney cancer	5.46e-05	0.000403	CcSEcCtD
Indomethacin—Shock—Paclitaxel—kidney cancer	5.46e-05	0.000403	CcSEcCtD
Indomethacin—Vomiting—Sorafenib—kidney cancer	5.46e-05	0.000402	CcSEcCtD
Indomethacin—Abdominal pain upper—Doxorubicin—kidney cancer	5.45e-05	0.000402	CcSEcCtD
Indomethacin—Thrombocytopenia—Paclitaxel—kidney cancer	5.43e-05	0.000401	CcSEcCtD
Indomethacin—Tachycardia—Paclitaxel—kidney cancer	5.42e-05	0.000399	CcSEcCtD
Indomethacin—Rash—Sorafenib—kidney cancer	5.41e-05	0.000399	CcSEcCtD
Indomethacin—Dermatitis—Sorafenib—kidney cancer	5.41e-05	0.000399	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	5.38e-05	0.000397	CcSEcCtD
Indomethacin—Headache—Sorafenib—kidney cancer	5.38e-05	0.000397	CcSEcCtD
Indomethacin—Hyperhidrosis—Paclitaxel—kidney cancer	5.36e-05	0.000396	CcSEcCtD
Indomethacin—Diarrhoea—Dactinomycin—kidney cancer	5.35e-05	0.000395	CcSEcCtD
Indomethacin—Anorexia—Paclitaxel—kidney cancer	5.29e-05	0.00039	CcSEcCtD
Indomethacin—Gastritis—Doxorubicin—kidney cancer	5.29e-05	0.00039	CcSEcCtD
Indomethacin—Muscular weakness—Doxorubicin—kidney cancer	5.27e-05	0.000388	CcSEcCtD
Indomethacin—Vision blurred—Capecitabine—kidney cancer	5.26e-05	0.000388	CcSEcCtD
Indomethacin—Vomiting—Sunitinib—kidney cancer	5.25e-05	0.000387	CcSEcCtD
Indomethacin—Body temperature increased—Gemcitabine—kidney cancer	5.24e-05	0.000386	CcSEcCtD
Indomethacin—Rash—Sunitinib—kidney cancer	5.21e-05	0.000384	CcSEcCtD
Indomethacin—Dermatitis—Sunitinib—kidney cancer	5.2e-05	0.000384	CcSEcCtD
Indomethacin—Abdominal distension—Doxorubicin—kidney cancer	5.2e-05	0.000383	CcSEcCtD
Indomethacin—Hypotension—Paclitaxel—kidney cancer	5.19e-05	0.000382	CcSEcCtD
Indomethacin—Ill-defined disorder—Capecitabine—kidney cancer	5.18e-05	0.000382	CcSEcCtD
Indomethacin—Headache—Sunitinib—kidney cancer	5.17e-05	0.000382	CcSEcCtD
Indomethacin—Asthma—Doxorubicin—kidney cancer	5.16e-05	0.000381	CcSEcCtD
Indomethacin—Anaemia—Capecitabine—kidney cancer	5.16e-05	0.00038	CcSEcCtD
Indomethacin—Hypersensitivity—Vincristine—kidney cancer	5.15e-05	0.00038	CcSEcCtD
Indomethacin—Nausea—Sorafenib—kidney cancer	5.1e-05	0.000376	CcSEcCtD
Indomethacin—Malaise—Capecitabine—kidney cancer	5.03e-05	0.000371	CcSEcCtD
Indomethacin—Insomnia—Paclitaxel—kidney cancer	5.02e-05	0.00037	CcSEcCtD
Indomethacin—Vertigo—Capecitabine—kidney cancer	5.01e-05	0.00037	CcSEcCtD
Indomethacin—Asthenia—Vincristine—kidney cancer	5.01e-05	0.00037	CcSEcCtD
Indomethacin—Syncope—Capecitabine—kidney cancer	5e-05	0.000369	CcSEcCtD
Indomethacin—Leukopenia—Capecitabine—kidney cancer	4.99e-05	0.000368	CcSEcCtD
Indomethacin—Paraesthesia—Paclitaxel—kidney cancer	4.98e-05	0.000367	CcSEcCtD
Indomethacin—Vomiting—Dactinomycin—kidney cancer	4.97e-05	0.000367	CcSEcCtD
Indomethacin—Dyspnoea—Paclitaxel—kidney cancer	4.95e-05	0.000365	CcSEcCtD
Indomethacin—Somnolence—Paclitaxel—kidney cancer	4.93e-05	0.000364	CcSEcCtD
Indomethacin—Palpitations—Capecitabine—kidney cancer	4.93e-05	0.000364	CcSEcCtD
Indomethacin—Rash—Dactinomycin—kidney cancer	4.93e-05	0.000364	CcSEcCtD
Indomethacin—Nausea—Sunitinib—kidney cancer	4.91e-05	0.000362	CcSEcCtD
Indomethacin—Loss of consciousness—Capecitabine—kidney cancer	4.9e-05	0.000362	CcSEcCtD
Indomethacin—Pancytopenia—Doxorubicin—kidney cancer	4.9e-05	0.000361	CcSEcCtD
Indomethacin—Dyspepsia—Paclitaxel—kidney cancer	4.88e-05	0.00036	CcSEcCtD
Indomethacin—Decreased appetite—Paclitaxel—kidney cancer	4.82e-05	0.000356	CcSEcCtD
Indomethacin—Hypertension—Capecitabine—kidney cancer	4.82e-05	0.000355	CcSEcCtD
Indomethacin—Fatigue—Paclitaxel—kidney cancer	4.78e-05	0.000353	CcSEcCtD
Indomethacin—Diarrhoea—Vincristine—kidney cancer	4.78e-05	0.000352	CcSEcCtD
Indomethacin—Pollakiuria—Doxorubicin—kidney cancer	4.77e-05	0.000352	CcSEcCtD
Indomethacin—Asthenia—Gemcitabine—kidney cancer	4.76e-05	0.000351	CcSEcCtD
Indomethacin—Chest pain—Capecitabine—kidney cancer	4.75e-05	0.00035	CcSEcCtD
Indomethacin—Pain—Paclitaxel—kidney cancer	4.75e-05	0.00035	CcSEcCtD
Indomethacin—Constipation—Paclitaxel—kidney cancer	4.75e-05	0.00035	CcSEcCtD
Indomethacin—Anxiety—Capecitabine—kidney cancer	4.73e-05	0.000349	CcSEcCtD
Indomethacin—Weight increased—Doxorubicin—kidney cancer	4.7e-05	0.000346	CcSEcCtD
Indomethacin—Discomfort—Capecitabine—kidney cancer	4.69e-05	0.000346	CcSEcCtD
Indomethacin—Pruritus—Gemcitabine—kidney cancer	4.69e-05	0.000346	CcSEcCtD
Indomethacin—Hyperglycaemia—Doxorubicin—kidney cancer	4.66e-05	0.000343	CcSEcCtD
Indomethacin—Nausea—Dactinomycin—kidney cancer	4.64e-05	0.000342	CcSEcCtD
Indomethacin—Dizziness—Vincristine—kidney cancer	4.62e-05	0.000341	CcSEcCtD
Indomethacin—Drowsiness—Doxorubicin—kidney cancer	4.6e-05	0.000339	CcSEcCtD
Indomethacin—Confusional state—Capecitabine—kidney cancer	4.59e-05	0.000339	CcSEcCtD
Indomethacin—Feeling abnormal—Paclitaxel—kidney cancer	4.57e-05	0.000337	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	4.56e-05	0.000336	CcSEcCtD
Indomethacin—Oedema—Capecitabine—kidney cancer	4.55e-05	0.000336	CcSEcCtD
Indomethacin—Gastrointestinal pain—Paclitaxel—kidney cancer	4.54e-05	0.000335	CcSEcCtD
Indomethacin—Diarrhoea—Gemcitabine—kidney cancer	4.53e-05	0.000334	CcSEcCtD
Indomethacin—Renal failure—Doxorubicin—kidney cancer	4.52e-05	0.000334	CcSEcCtD
Indomethacin—Neuropathy peripheral—Doxorubicin—kidney cancer	4.51e-05	0.000333	CcSEcCtD
Indomethacin—Stomatitis—Doxorubicin—kidney cancer	4.49e-05	0.000331	CcSEcCtD
Indomethacin—Jaundice—Doxorubicin—kidney cancer	4.49e-05	0.000331	CcSEcCtD
Indomethacin—Shock—Capecitabine—kidney cancer	4.48e-05	0.00033	CcSEcCtD
Indomethacin—Thrombocytopenia—Capecitabine—kidney cancer	4.46e-05	0.000329	CcSEcCtD
Indomethacin—Tachycardia—Capecitabine—kidney cancer	4.44e-05	0.000328	CcSEcCtD
Indomethacin—Vomiting—Vincristine—kidney cancer	4.44e-05	0.000328	CcSEcCtD
Indomethacin—Sweating—Doxorubicin—kidney cancer	4.41e-05	0.000325	CcSEcCtD
Indomethacin—Urticaria—Paclitaxel—kidney cancer	4.41e-05	0.000325	CcSEcCtD
Indomethacin—Rash—Vincristine—kidney cancer	4.4e-05	0.000325	CcSEcCtD
Indomethacin—Hyperhidrosis—Capecitabine—kidney cancer	4.4e-05	0.000325	CcSEcCtD
Indomethacin—Dermatitis—Vincristine—kidney cancer	4.4e-05	0.000325	CcSEcCtD
Indomethacin—Haematuria—Doxorubicin—kidney cancer	4.39e-05	0.000324	CcSEcCtD
Indomethacin—Abdominal pain—Paclitaxel—kidney cancer	4.39e-05	0.000323	CcSEcCtD
Indomethacin—Body temperature increased—Paclitaxel—kidney cancer	4.39e-05	0.000323	CcSEcCtD
Indomethacin—Headache—Vincristine—kidney cancer	4.38e-05	0.000323	CcSEcCtD
Indomethacin—Epistaxis—Doxorubicin—kidney cancer	4.34e-05	0.00032	CcSEcCtD
Indomethacin—Anorexia—Capecitabine—kidney cancer	4.34e-05	0.00032	CcSEcCtD
Indomethacin—Agranulocytosis—Doxorubicin—kidney cancer	4.29e-05	0.000317	CcSEcCtD
Indomethacin—Hypotension—Capecitabine—kidney cancer	4.26e-05	0.000314	CcSEcCtD
Indomethacin—Vomiting—Gemcitabine—kidney cancer	4.21e-05	0.000311	CcSEcCtD
Indomethacin—Bradycardia—Doxorubicin—kidney cancer	4.21e-05	0.00031	CcSEcCtD
Indomethacin—Rash—Gemcitabine—kidney cancer	4.18e-05	0.000308	CcSEcCtD
Indomethacin—Dermatitis—Gemcitabine—kidney cancer	4.17e-05	0.000308	CcSEcCtD
Indomethacin—Haemoglobin—Doxorubicin—kidney cancer	4.15e-05	0.000306	CcSEcCtD
Indomethacin—Headache—Gemcitabine—kidney cancer	4.15e-05	0.000306	CcSEcCtD
Indomethacin—Nausea—Vincristine—kidney cancer	4.15e-05	0.000306	CcSEcCtD
Indomethacin—Hepatitis—Doxorubicin—kidney cancer	4.13e-05	0.000305	CcSEcCtD
Indomethacin—Haemorrhage—Doxorubicin—kidney cancer	4.13e-05	0.000305	CcSEcCtD
Indomethacin—Insomnia—Capecitabine—kidney cancer	4.12e-05	0.000304	CcSEcCtD
Indomethacin—Paraesthesia—Capecitabine—kidney cancer	4.09e-05	0.000302	CcSEcCtD
Indomethacin—Hypersensitivity—Paclitaxel—kidney cancer	4.09e-05	0.000301	CcSEcCtD
Indomethacin—Dyspnoea—Capecitabine—kidney cancer	4.06e-05	0.000299	CcSEcCtD
Indomethacin—Dyspepsia—Capecitabine—kidney cancer	4.01e-05	0.000296	CcSEcCtD
Indomethacin—Asthenia—Paclitaxel—kidney cancer	3.98e-05	0.000294	CcSEcCtD
Indomethacin—Decreased appetite—Capecitabine—kidney cancer	3.96e-05	0.000292	CcSEcCtD
Indomethacin—Nausea—Gemcitabine—kidney cancer	3.94e-05	0.00029	CcSEcCtD
Indomethacin—Fatigue—Capecitabine—kidney cancer	3.93e-05	0.000289	CcSEcCtD
Indomethacin—Pruritus—Paclitaxel—kidney cancer	3.93e-05	0.000289	CcSEcCtD
Indomethacin—Erythema multiforme—Doxorubicin—kidney cancer	3.91e-05	0.000288	CcSEcCtD
Indomethacin—Pain—Capecitabine—kidney cancer	3.89e-05	0.000287	CcSEcCtD
Indomethacin—Constipation—Capecitabine—kidney cancer	3.89e-05	0.000287	CcSEcCtD
Indomethacin—Tinnitus—Doxorubicin—kidney cancer	3.85e-05	0.000284	CcSEcCtD
Indomethacin—Flushing—Doxorubicin—kidney cancer	3.83e-05	0.000283	CcSEcCtD
Indomethacin—Diarrhoea—Paclitaxel—kidney cancer	3.8e-05	0.00028	CcSEcCtD
Indomethacin—Feeling abnormal—Capecitabine—kidney cancer	3.75e-05	0.000277	CcSEcCtD
Indomethacin—Gastrointestinal pain—Capecitabine—kidney cancer	3.72e-05	0.000275	CcSEcCtD
Indomethacin—Arrhythmia—Doxorubicin—kidney cancer	3.69e-05	0.000272	CcSEcCtD
Indomethacin—Dizziness—Paclitaxel—kidney cancer	3.67e-05	0.000271	CcSEcCtD
Indomethacin—Alopecia—Doxorubicin—kidney cancer	3.65e-05	0.000269	CcSEcCtD
Indomethacin—Urticaria—Capecitabine—kidney cancer	3.62e-05	0.000267	CcSEcCtD
Indomethacin—Body temperature increased—Capecitabine—kidney cancer	3.6e-05	0.000265	CcSEcCtD
Indomethacin—Abdominal pain—Capecitabine—kidney cancer	3.6e-05	0.000265	CcSEcCtD
Indomethacin—Erythema—Doxorubicin—kidney cancer	3.6e-05	0.000265	CcSEcCtD
Indomethacin—Flatulence—Doxorubicin—kidney cancer	3.54e-05	0.000261	CcSEcCtD
Indomethacin—Tension—Doxorubicin—kidney cancer	3.53e-05	0.00026	CcSEcCtD
Indomethacin—Vomiting—Paclitaxel—kidney cancer	3.53e-05	0.00026	CcSEcCtD
Indomethacin—Rash—Paclitaxel—kidney cancer	3.5e-05	0.000258	CcSEcCtD
Indomethacin—Dermatitis—Paclitaxel—kidney cancer	3.5e-05	0.000258	CcSEcCtD
Indomethacin—Nervousness—Doxorubicin—kidney cancer	3.49e-05	0.000258	CcSEcCtD
Indomethacin—Headache—Paclitaxel—kidney cancer	3.48e-05	0.000256	CcSEcCtD
Indomethacin—Vision blurred—Doxorubicin—kidney cancer	3.39e-05	0.00025	CcSEcCtD
Indomethacin—Hypersensitivity—Capecitabine—kidney cancer	3.35e-05	0.000247	CcSEcCtD
Indomethacin—Ill-defined disorder—Doxorubicin—kidney cancer	3.34e-05	0.000246	CcSEcCtD
Indomethacin—Anaemia—Doxorubicin—kidney cancer	3.32e-05	0.000245	CcSEcCtD
Indomethacin—Nausea—Paclitaxel—kidney cancer	3.3e-05	0.000243	CcSEcCtD
Indomethacin—Asthenia—Capecitabine—kidney cancer	3.27e-05	0.000241	CcSEcCtD
Indomethacin—Malaise—Doxorubicin—kidney cancer	3.24e-05	0.000239	CcSEcCtD
Indomethacin—Vertigo—Doxorubicin—kidney cancer	3.23e-05	0.000238	CcSEcCtD
Indomethacin—Syncope—Doxorubicin—kidney cancer	3.23e-05	0.000238	CcSEcCtD
Indomethacin—Pruritus—Capecitabine—kidney cancer	3.22e-05	0.000238	CcSEcCtD
Indomethacin—Leukopenia—Doxorubicin—kidney cancer	3.22e-05	0.000237	CcSEcCtD
Indomethacin—Palpitations—Doxorubicin—kidney cancer	3.18e-05	0.000234	CcSEcCtD
Indomethacin—Loss of consciousness—Doxorubicin—kidney cancer	3.16e-05	0.000233	CcSEcCtD
Indomethacin—Convulsion—Doxorubicin—kidney cancer	3.12e-05	0.00023	CcSEcCtD
Indomethacin—Diarrhoea—Capecitabine—kidney cancer	3.12e-05	0.00023	CcSEcCtD
Indomethacin—Hypertension—Doxorubicin—kidney cancer	3.11e-05	0.000229	CcSEcCtD
Indomethacin—Chest pain—Doxorubicin—kidney cancer	3.06e-05	0.000226	CcSEcCtD
Indomethacin—Anxiety—Doxorubicin—kidney cancer	3.05e-05	0.000225	CcSEcCtD
Indomethacin—Discomfort—Doxorubicin—kidney cancer	3.03e-05	0.000223	CcSEcCtD
Indomethacin—Dizziness—Capecitabine—kidney cancer	3.01e-05	0.000222	CcSEcCtD
Indomethacin—Confusional state—Doxorubicin—kidney cancer	2.96e-05	0.000218	CcSEcCtD
Indomethacin—Anaphylactic shock—Doxorubicin—kidney cancer	2.94e-05	0.000216	CcSEcCtD
Indomethacin—Oedema—Doxorubicin—kidney cancer	2.94e-05	0.000216	CcSEcCtD
Indomethacin—Vomiting—Capecitabine—kidney cancer	2.9e-05	0.000213	CcSEcCtD
Indomethacin—Shock—Doxorubicin—kidney cancer	2.89e-05	0.000213	CcSEcCtD
Indomethacin—Thrombocytopenia—Doxorubicin—kidney cancer	2.87e-05	0.000212	CcSEcCtD
Indomethacin—Rash—Capecitabine—kidney cancer	2.87e-05	0.000212	CcSEcCtD
Indomethacin—Dermatitis—Capecitabine—kidney cancer	2.87e-05	0.000212	CcSEcCtD
Indomethacin—Tachycardia—Doxorubicin—kidney cancer	2.86e-05	0.000211	CcSEcCtD
Indomethacin—Headache—Capecitabine—kidney cancer	2.85e-05	0.00021	CcSEcCtD
Indomethacin—Hyperhidrosis—Doxorubicin—kidney cancer	2.84e-05	0.000209	CcSEcCtD
Indomethacin—Anorexia—Doxorubicin—kidney cancer	2.8e-05	0.000206	CcSEcCtD
Indomethacin—Hypotension—Doxorubicin—kidney cancer	2.74e-05	0.000202	CcSEcCtD
Indomethacin—Nausea—Capecitabine—kidney cancer	2.7e-05	0.000199	CcSEcCtD
Indomethacin—Insomnia—Doxorubicin—kidney cancer	2.65e-05	0.000196	CcSEcCtD
Indomethacin—Paraesthesia—Doxorubicin—kidney cancer	2.64e-05	0.000194	CcSEcCtD
Indomethacin—Dyspnoea—Doxorubicin—kidney cancer	2.62e-05	0.000193	CcSEcCtD
Indomethacin—Somnolence—Doxorubicin—kidney cancer	2.61e-05	0.000192	CcSEcCtD
Indomethacin—Dyspepsia—Doxorubicin—kidney cancer	2.58e-05	0.000191	CcSEcCtD
Indomethacin—Decreased appetite—Doxorubicin—kidney cancer	2.55e-05	0.000188	CcSEcCtD
Indomethacin—Fatigue—Doxorubicin—kidney cancer	2.53e-05	0.000187	CcSEcCtD
Indomethacin—Pain—Doxorubicin—kidney cancer	2.51e-05	0.000185	CcSEcCtD
Indomethacin—Constipation—Doxorubicin—kidney cancer	2.51e-05	0.000185	CcSEcCtD
Indomethacin—Feeling abnormal—Doxorubicin—kidney cancer	2.42e-05	0.000178	CcSEcCtD
Indomethacin—Gastrointestinal pain—Doxorubicin—kidney cancer	2.4e-05	0.000177	CcSEcCtD
Indomethacin—Urticaria—Doxorubicin—kidney cancer	2.33e-05	0.000172	CcSEcCtD
Indomethacin—Body temperature increased—Doxorubicin—kidney cancer	2.32e-05	0.000171	CcSEcCtD
Indomethacin—Abdominal pain—Doxorubicin—kidney cancer	2.32e-05	0.000171	CcSEcCtD
Indomethacin—Hypersensitivity—Doxorubicin—kidney cancer	2.16e-05	0.000159	CcSEcCtD
Indomethacin—Asthenia—Doxorubicin—kidney cancer	2.11e-05	0.000155	CcSEcCtD
Indomethacin—Pruritus—Doxorubicin—kidney cancer	2.08e-05	0.000153	CcSEcCtD
Indomethacin—Diarrhoea—Doxorubicin—kidney cancer	2.01e-05	0.000148	CcSEcCtD
Indomethacin—Dizziness—Doxorubicin—kidney cancer	1.94e-05	0.000143	CcSEcCtD
Indomethacin—Vomiting—Doxorubicin—kidney cancer	1.87e-05	0.000138	CcSEcCtD
Indomethacin—Rash—Doxorubicin—kidney cancer	1.85e-05	0.000136	CcSEcCtD
Indomethacin—Dermatitis—Doxorubicin—kidney cancer	1.85e-05	0.000136	CcSEcCtD
Indomethacin—Headache—Doxorubicin—kidney cancer	1.84e-05	0.000136	CcSEcCtD
Indomethacin—Nausea—Doxorubicin—kidney cancer	1.74e-05	0.000129	CcSEcCtD
Indomethacin—AKR1C3—Metabolism—PTEN—kidney cancer	4.21e-06	5.51e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—APC—kidney cancer	4.2e-06	5.49e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KIT—kidney cancer	4.2e-06	5.49e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—GSTM1—kidney cancer	4.19e-06	5.49e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PTGS2—kidney cancer	4.19e-06	5.48e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CYP1A1—kidney cancer	4.18e-06	5.47e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—MYC—kidney cancer	4.18e-06	5.47e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—RAF1—kidney cancer	4.18e-06	5.46e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.17e-06	5.46e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—RELA—kidney cancer	4.16e-06	5.44e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.15e-06	5.43e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—ERBB2—kidney cancer	4.13e-06	5.4e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ITPR2—kidney cancer	4.12e-06	5.4e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.12e-06	5.39e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—MAPK1—kidney cancer	4.09e-06	5.35e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MTOR—kidney cancer	4.08e-06	5.33e-05	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—PIK3CA—kidney cancer	4.06e-06	5.32e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GSTP1—kidney cancer	4.06e-06	5.31e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—BCHE—kidney cancer	4.05e-06	5.3e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—MAPK3—kidney cancer	4.02e-06	5.26e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—MAPK3—kidney cancer	4.01e-06	5.25e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—SLC5A5—kidney cancer	4e-06	5.23e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—POMC—kidney cancer	3.99e-06	5.23e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CRABP1—kidney cancer	3.98e-06	5.21e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—POMC—kidney cancer	3.98e-06	5.21e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—POMC—kidney cancer	3.98e-06	5.21e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	3.98e-06	5.2e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CYP1A1—kidney cancer	3.97e-06	5.2e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—BRAF—kidney cancer	3.94e-06	5.16e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.91e-06	5.12e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KIT—kidney cancer	3.91e-06	5.12e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—APC—kidney cancer	3.91e-06	5.12e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—MYC—kidney cancer	3.9e-06	5.11e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CRABP1—kidney cancer	3.89e-06	5.09e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—SLC2A1—kidney cancer	3.86e-06	5.05e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—KRAS—kidney cancer	3.86e-06	5.05e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ABCB1—kidney cancer	3.84e-06	5.03e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CDKN1B—kidney cancer	3.83e-06	5.01e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—MAPK1—kidney cancer	3.82e-06	5e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.82e-06	5e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.8e-06	4.97e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	3.79e-06	4.95e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—POMC—kidney cancer	3.76e-06	4.92e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTT1—kidney cancer	3.76e-06	4.92e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ACHE—kidney cancer	3.76e-06	4.92e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL2—kidney cancer	3.74e-06	4.9e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GSTM1—kidney cancer	3.73e-06	4.88e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN2B—kidney cancer	3.73e-06	4.88e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ITPR2—kidney cancer	3.7e-06	4.84e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—BRAF—kidney cancer	3.68e-06	4.81e-05	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—PIK3CA—kidney cancer	3.65e-06	4.78e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PTEN—kidney cancer	3.65e-06	4.78e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCND1—kidney cancer	3.65e-06	4.78e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—JUN—kidney cancer	3.64e-06	4.77e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CRABP1—kidney cancer	3.63e-06	4.75e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CTNNB1—kidney cancer	3.61e-06	4.73e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ITPR2—kidney cancer	3.61e-06	4.73e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—KRAS—kidney cancer	3.61e-06	4.73e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.56e-06	4.66e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SCARB1—kidney cancer	3.56e-06	4.66e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PIK3CA—kidney cancer	3.55e-06	4.64e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CYP1A1—kidney cancer	3.54e-06	4.63e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS1—kidney cancer	3.52e-06	4.61e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PTEN—kidney cancer	3.52e-06	4.61e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—POMC—kidney cancer	3.47e-06	4.53e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PIK3CA—kidney cancer	3.46e-06	4.52e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PSMD7—kidney cancer	3.46e-06	4.52e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—RAF1—kidney cancer	3.44e-06	4.51e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.44e-06	4.5e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.41e-06	4.47e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTT1—kidney cancer	3.38e-06	4.42e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ACHE—kidney cancer	3.38e-06	4.42e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ITPR2—kidney cancer	3.38e-06	4.42e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—PIK3CA—kidney cancer	3.32e-06	4.34e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ACHE—kidney cancer	3.3e-06	4.31e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTT1—kidney cancer	3.3e-06	4.31e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—RAF1—kidney cancer	3.29e-06	4.31e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—RELA—kidney cancer	3.28e-06	4.29e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—BCHE—kidney cancer	3.28e-06	4.29e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.27e-06	4.28e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.27e-06	4.27e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ERBB2—kidney cancer	3.26e-06	4.26e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SLC5A5—kidney cancer	3.24e-06	4.23e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—POMC—kidney cancer	3.23e-06	4.23e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—POMC—kidney cancer	3.23e-06	4.23e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GSTP1—kidney cancer	3.22e-06	4.22e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MTOR—kidney cancer	3.22e-06	4.21e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SCARB1—kidney cancer	3.2e-06	4.18e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—VEGFA—kidney cancer	3.18e-06	4.16e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—kidney cancer	3.17e-06	4.15e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—kidney cancer	3.17e-06	4.15e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS1—kidney cancer	3.16e-06	4.14e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SLC2A1—kidney cancer	3.13e-06	4.09e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SCARB1—kidney cancer	3.12e-06	4.08e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—POMC—kidney cancer	3.12e-06	4.08e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.11e-06	4.07e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PSMD7—kidney cancer	3.1e-06	4.06e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS1—kidney cancer	3.09e-06	4.04e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IL2—kidney cancer	3.09e-06	4.04e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTT1—kidney cancer	3.08e-06	4.03e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ACHE—kidney cancer	3.08e-06	4.03e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—RAF1—kidney cancer	3.07e-06	4.02e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ABCB1—kidney cancer	3.05e-06	3.99e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—ERBB2—kidney cancer	3.04e-06	3.97e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.03e-06	3.97e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PSMD7—kidney cancer	3.03e-06	3.96e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CDKN1B—kidney cancer	3.02e-06	3.95e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MAPK3—kidney cancer	3.01e-06	3.94e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—kidney cancer	3e-06	3.93e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MTOR—kidney cancer	3e-06	3.92e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CD4—kidney cancer	2.99e-06	3.91e-05	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	2.98e-06	3.9e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HIF1A—kidney cancer	2.98e-06	3.9e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TSC2—kidney cancer	2.97e-06	3.89e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PIK3CA—kidney cancer	2.97e-06	3.89e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—kidney cancer	2.97e-06	3.89e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—POMC—kidney cancer	2.96e-06	3.88e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GSTM1—kidney cancer	2.96e-06	3.87e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL2—kidney cancer	2.95e-06	3.86e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—BCHE—kidney cancer	2.94e-06	3.85e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MYC—kidney cancer	2.93e-06	3.83e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SCARB1—kidney cancer	2.91e-06	3.81e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SLC5A5—kidney cancer	2.91e-06	3.8e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.9e-06	3.8e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS1—kidney cancer	2.88e-06	3.77e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCND1—kidney cancer	2.88e-06	3.77e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MAPK3—kidney cancer	2.88e-06	3.76e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—JUN—kidney cancer	2.87e-06	3.76e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—BCHE—kidney cancer	2.87e-06	3.76e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MAPK1—kidney cancer	2.86e-06	3.75e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CTNNB1—kidney cancer	2.85e-06	3.73e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SLC5A5—kidney cancer	2.84e-06	3.71e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PSMD7—kidney cancer	2.83e-06	3.7e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CDKN1B—kidney cancer	2.81e-06	3.68e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CYP1A1—kidney cancer	2.81e-06	3.67e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SLC2A1—kidney cancer	2.81e-06	3.67e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MYC—kidney cancer	2.8e-06	3.66e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PTEN—kidney cancer	2.78e-06	3.64e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTEN—kidney cancer	2.77e-06	3.62e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTEN—kidney cancer	2.77e-06	3.62e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—kidney cancer	2.76e-06	3.62e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SLC2A1—kidney cancer	2.74e-06	3.58e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.72e-06	3.56e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KRAS—kidney cancer	2.71e-06	3.54e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—BCHE—kidney cancer	2.68e-06	3.51e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CTNNB1—kidney cancer	2.66e-06	3.48e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC5A5—kidney cancer	2.65e-06	3.47e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.64e-06	3.46e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—POMC—kidney cancer	2.64e-06	3.45e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KIT—kidney cancer	2.63e-06	3.43e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APC—kidney cancer	2.63e-06	3.43e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—kidney cancer	2.62e-06	3.43e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTEN—kidney cancer	2.62e-06	3.43e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.61e-06	3.42e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTP1—kidney cancer	2.61e-06	3.41e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTEN—kidney cancer	2.59e-06	3.39e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—kidney cancer	2.58e-06	3.37e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—kidney cancer	2.58e-06	3.37e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PIK3CA—kidney cancer	2.58e-06	3.37e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC2A1—kidney cancer	2.56e-06	3.35e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—kidney cancer	2.51e-06	3.28e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—kidney cancer	2.49e-06	3.25e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PIK3CA—kidney cancer	2.49e-06	3.25e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.48e-06	3.25e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—MAPK3—kidney cancer	2.48e-06	3.25e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—BRAF—kidney cancer	2.47e-06	3.23e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ABCB1—kidney cancer	2.47e-06	3.23e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTEN—kidney cancer	2.41e-06	3.15e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—kidney cancer	2.4e-06	3.15e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTM1—kidney cancer	2.4e-06	3.13e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK3—kidney cancer	2.37e-06	3.11e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.37e-06	3.11e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—kidney cancer	2.36e-06	3.09e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—MAPK1—kidney cancer	2.36e-06	3.09e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTP1—kidney cancer	2.34e-06	3.06e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MYC—kidney cancer	2.31e-06	3.02e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.31e-06	3.02e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTP1—kidney cancer	2.28e-06	2.99e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP1A1—kidney cancer	2.27e-06	2.97e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK1—kidney cancer	2.26e-06	2.96e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTEN—kidney cancer	2.25e-06	2.94e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTEN—kidney cancer	2.25e-06	2.94e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KRAS—kidney cancer	2.23e-06	2.92e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ABCB1—kidney cancer	2.22e-06	2.9e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MAPK3—kidney cancer	2.21e-06	2.9e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTEN—kidney cancer	2.17e-06	2.84e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.16e-06	2.83e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MYC—kidney cancer	2.15e-06	2.82e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTM1—kidney cancer	2.15e-06	2.81e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KRAS—kidney cancer	2.13e-06	2.79e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTP1—kidney cancer	2.13e-06	2.79e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MAPK1—kidney cancer	2.11e-06	2.76e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—kidney cancer	2.1e-06	2.75e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTM1—kidney cancer	2.1e-06	2.75e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—POMC—kidney cancer	2.09e-06	2.74e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTEN—kidney cancer	2.06e-06	2.7e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—RAF1—kidney cancer	2.06e-06	2.7e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CA—kidney cancer	2.05e-06	2.68e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.04e-06	2.67e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ERBB2—kidney cancer	2.04e-06	2.67e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ABCB1—kidney cancer	2.02e-06	2.64e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MTOR—kidney cancer	2.01e-06	2.63e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CD4—kidney cancer	2.01e-06	2.63e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP1A1—kidney cancer	1.99e-06	2.6e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KRAS—kidney cancer	1.99e-06	2.6e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—kidney cancer	1.98e-06	2.59e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTM1—kidney cancer	1.96e-06	2.57e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CA—kidney cancer	1.96e-06	2.56e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CA—kidney cancer	1.95e-06	2.56e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CA—kidney cancer	1.95e-06	2.56e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—kidney cancer	1.9e-06	2.48e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1B—kidney cancer	1.89e-06	2.47e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.87e-06	2.44e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.86e-06	2.43e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CA—kidney cancer	1.85e-06	2.42e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTEN—kidney cancer	1.83e-06	2.4e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CA—kidney cancer	1.83e-06	2.39e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CTNNB1—kidney cancer	1.78e-06	2.33e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PTEN—kidney cancer	1.74e-06	2.27e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CA—kidney cancer	1.7e-06	2.22e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—POMC—kidney cancer	1.69e-06	2.22e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.67e-06	2.19e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CA—kidney cancer	1.59e-06	2.08e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CA—kidney cancer	1.59e-06	2.08e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CA—kidney cancer	1.53e-06	2e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.53e-06	2e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—POMC—kidney cancer	1.52e-06	1.99e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAPK3—kidney cancer	1.49e-06	1.94e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—POMC—kidney cancer	1.48e-06	1.94e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PTEN—kidney cancer	1.46e-06	1.9e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CA—kidney cancer	1.45e-06	1.9e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MYC—kidney cancer	1.44e-06	1.89e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAPK1—kidney cancer	1.41e-06	1.85e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—POMC—kidney cancer	1.39e-06	1.81e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—kidney cancer	1.35e-06	1.77e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KRAS—kidney cancer	1.33e-06	1.75e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CA—kidney cancer	1.29e-06	1.69e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CA—kidney cancer	1.23e-06	1.6e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—kidney cancer	1.21e-06	1.59e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—kidney cancer	1.18e-06	1.55e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTEN—kidney cancer	1.18e-06	1.54e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—kidney cancer	1.11e-06	1.45e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTEN—kidney cancer	1.06e-06	1.38e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTEN—kidney cancer	1.03e-06	1.35e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CA—kidney cancer	1.03e-06	1.34e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTEN—kidney cancer	9.64e-07	1.26e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CA—kidney cancer	8.31e-07	1.09e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CA—kidney cancer	7.46e-07	9.76e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CA—kidney cancer	7.28e-07	9.53e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CA—kidney cancer	6.8e-07	8.9e-06	CbGpPWpGaD
